apdn: the balance sheet

MyFinsight

For the quarter ending 2025-06-30, APDN has $9,934,746 in assets. $2,946,702 in debts. $4,727,677 in cash and cash equivalents.

Unit: Dollar

Balance Sheets	2025-06-30
Inventories	338,723
Prepaid expenses and other current assets	338,447
Cash and cash equivalents	4,727,677
Current assets of discontinued operations	25,008
Accounts receivable, net of allowance for credit losses of 80,423 and 75,000 at june 30, 2025 and september 30, 2024, respectively	199,047
Total current assets	5,628,902
Restricted cash	750,000
Property and equipment, net	511,203
Operating right of use asset	334,402
Intangible assets	2,698,975
Noncurrent assets of discontinued operations	11,264
Total assets	9,934,746

Accounts payable and accrued liabilities	1,564,707
Operating lease liability, current	334,403
Current liabilities of discontinued operations	124,565
Deferred revenue	12,285
Total current liabilities	2,035,960
Deferred tax liability, net	684,115
Deferred revenue, long term	194,000
Long term accrued liabilities	31,467
Warrants classified as a liability	1,160
Total liabilities	2,946,702
Accumulated deficit	-373,888,601
Common stock, par value 0.001 per share 200,000,000 shares authorized as of june 30, 2025 and september 30, 2024 901,500 and 13,755 shares issued and outstanding as of june 30, 2025 and september 30, 2024, respectively	902
Additional paid in capital	381,150,267
Applied dna sciences, inc. stockholders' equity	7,262,568
Noncontrolling interest	-274,524
Total equity	6,988,044
Total liabilities and equity	9,934,746